The experimental therapy takes just a few weeks and removed insulin from the equation for 86% of trial participants.

"These findings are very encouraging, suggesting that ReCET is a safe and feasible procedure that, when combined with ...

A new treatment combining ReCET and semaglutide could eliminate the need for insulin in type 2 diabetes, with 86% of ...

Rachel Connor, Director of Research Partnerships at Breakthrough T1D, believes this pioneering study could “pave the way” for ...

Breakthrough stem cell transplants for diabetes have allowed patients to produce their own insulin, offering hope for a ...

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...

The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...

Type 2 diabetes is a common condition in which the body struggles to use insulin properly, causing blood sugar levels to rise ...

Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that ...

Scientists from Yale and other research institutions have discovered that a drug originally developed to treat type 2 ...